Home
Conditions
Diffuse Large B Cell Lymphoma

Clinical trial condition

Diffuse Large B Cell Lymphoma

Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

165 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Diffuse Large B Cell Lymphoma trial results

Completed

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

NCT01241734

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

NCT01679119

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stoke Mandeville Hospital (including Wycombe Hospital) Aylesbury, United Kingdom

North Hampshire Hospital Basingstoke, United Kingdom

Royal United Hospital Bath, United Kingdom

Royal Bournemouth Hospital Bournemouth, United Kingdom

View all 40 locations

View Trial Details

Completed

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

NCT04319237

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

NCT04282018

Conditions: Advanced Solid Tumor, Chronic Disease, Chronic Lymphocytic Leukemia, +27 more
Locations: Blacktown Cancer and Haematology Centre Blacktown, New South Wales, Australia

Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia

Pindara Private Hospital Benowa, Queensland, Australia

Gallipoli Medical Research Foundation Greenslopes, Queensland, Australia

View all 24 locations

View Trial Details

Completed

A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy

NCT04316624

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

NCT04067414

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

NCT05694364

Conditions: Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Kinetics of Circulating Tumor DNA in Lymphoma Treated by Immuno-chemotherapy

NCT06141772

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Centre Henri Becquerel Rouen, France

View Trial Details

Completed

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

NCT06004167

Conditions: Diffuse Large B Cell Lymphoma, Disease Attributes, Follicular Lymphoma, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

NCT04214626

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China

View Trial Details

Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma trial results

Related conditions